Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Patent licensed to Endorex/Elan joint venture covers mucosal delivery systems

Nov. 26, 1999

Bristol-Myers Squibb pioneers pharmacogenomic approach to cancer therapy, enters new alliance

Nov. 24, 1999

Ivax and BMS establish collaboration agreement in oncology, respiratory fields

Nov. 22, 1999

LMW amido acid favorably influences PK/PD of porcine insulin delivered to the lungs

Nov. 22, 1999

Pharmacopeia and Otsuka enter drug discovery collaboration

Nov. 18, 1999

Genetronics and Boehringer Ingelheim enter collaborative gene therapy agreement

Nov. 12, 1999

CombiChem reaches second milestone in collaboration with Teijin

Nov. 10, 1999

Exelixis and Pharmacia & Upjohn expand collaboration

Nov. 10, 1999

ASN presentation for VNA-932, a potent and selective, nonpeptide V2 agonist

Nov. 9, 1999

Helix BioPharma finalizes acquisition of PharmaDerm

Nov. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 24, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026